We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

OPERON S.A.

Operon is engaged in the R&D and manufacturing of in vitro diagnostic products, including ready-to-use ELISA and mole... read more Featured Products: More products

Download Mobile App




Noninvasive Method Determines Subclinical Childhood Celiac Disease

By LabMedica International staff writers
Posted on 29 Mar 2016
A new, simple and noninvasive method has been developed to determine whether a child aged two to four years of age suffers from celiac disease (CD) or not, without the necessity of a blood extraction. More...
Silent celiac disease goes unnoticed to the eyes of the doctor because it presents minor symptoms, imperceptible even for the patient.

Celiac disease is a systemic disease caused by a permanent intolerance to gluten, which can be found in wheat, barley and rye, and it affects people with genetic predisposition. The symptoms are intestinal malabsorption, abdominal distension, diarrhea, abdominal pain, and extra-digestive including skin problems, joint pain, cephalalgia.

Scientists working in collaboration with those at the Virgen de las Nieves University Hospital (Granada, Spain) recruited 198 children aged two to four years, mean age 32.3 ± 9.2 months, and 53% were males. CD prevalence according to the serological tests was 3% (CI 95%, 1.4%–6.4%). Biopsies were used to confirm the diagnosis in all suspected cases. Cross-sectional study was carried in a sample population of children who were apparently healthy subjects from the same metropolitan area.

The team collected clinical, anthropometric, analytical, and serological variables. They also tested for anti-gliadin immunoglobulin A (IgA) and anti-transglutaminase IgG and IgA using a rapid immunochromatographic test CD1WB and CD2WB (Operon; Zaragoza, Spain). The tests detected six celiac children among the 198 who participated in the study, which is a very high prevalence of 3%, higher than the European mean. All of them presented no symptoms at all, or minor imperceptible symptoms which did not make their parents consult a pediatrician.

The sensitivity and negative predictive value of the CD2WB immunochromatographic test strip were 100% and 1, respectively. The sensitivity of CD1WB was 16.6% and its specificity was high at 89.1%. A positive outcome of the test will require further confirmation via blood extraction and assessment of the disease antibodies via other methods, but a negative outcome will allow the dismissal, with certainty, of being affected by the disease. The method does not require experienced personnel, although it has to be interpreted by health professionals, is quick as it only takes10 minutes, economic at EUR 10 to 12 per device, and, most important of all in the case of infant population, this method is less invasive than a blood extraction. The study was published originally published in September 2015 in the journal Pediatric Research.

Related Links:

Virgen de las Nieves University Hospital
Operon 



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.